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Abstract 
The impact of many unfavorable childhood traits or diseases, such as low birth weight and 
mental disorders, is not limited to childhood and adolescence, as they are also associated 
with poor outcomes in adulthood, such as cardiovascular disease. Insight into the genetic 
etiology of childhood and adolescent traits and disorders may therefore provide new 
perspectives, not only on how to improve wellbeing during childhood, but also how to 
prevent later adverse outcomes. To achieve the sample sizes required for genetic research, 
the Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) 
consortia were established. The majority of the participating cohorts are longitudinal 
population-based samples, but other cohorts with data on early childhood phenotypes are 
also involved. Cohorts often have a broad focus and collect(ed) data on various somatic and 
psychiatric traits as well as environmental factors. Genetic variants have been successfully 
identified for multiple traits, for example, birth weight, atopic dermatitis, childhood BMI, 
allergic sensitization, and pubertal growth. Furthermore, the results have shown that 
genetic factors also partly underlie the association with adult traits. As sample sizes are still 
increasing, it is expected that future analyses will identify additional variants. This, in 
combination with the development of innovative statistical methods, will provide detailed 
insight on the mechanisms underlying the transition from childhood to adult disorders.  
Both consortia welcome new collaborations. Policies and contact details are available from 
the corresponding authors of this manuscript and/or the consortium websites. 
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Background 
In countries with a high-sociodemographic index, the major contributors to burden of 
disease during childhood and adolescence are non-communicable diseases such as obesity, 
asthma or allergies, and psychiatric disorders. These have a large cumulative impact on 
individuals, families and society [1]. Moreover, many early-life traits track throughout 
childhood and adolescence into adulthood. Childhood obesity, for example, is associated 
with adult obesity and cardiovascular disease [2]. Several childhood psychiatric disorders 
persist into adolescence and adulthood or precede severe mental illness such as 
schizophrenia, which usually starts at late adolescence or early adulthood [3, 4]. Low birth 
weight, as a proxy for a suboptimal intrauterine environment, has been shown to be 
robustly associated with many later-life non-communicable traits, including cardiovascular, 
respiratory and psychiatric disorders (see e.g., 5-7). This prompted researchers, including 
those within the Developmental Origins of Health and Disease (DOHaD) field, to investigate 
the basis for the early origins of later life differences in health and disease. 
Insight into the etiology of childhood and adolescent traits and disorders may provide new 
perspectives, not only on how to improve wellbeing during childhood, but also how to 
prevent later adverse outcomes. Individual differences in developmental phenotypes, such 
as body weight and composition, behavioral problems, language skills, and their stability 
across ages are partly influenced by genetic factors [8-13]. Identifying the specific genetic 
variants that influence these traits, and the biological pathways through which they 
operate, can therefore help to unravel etiological mechanisms. Genetic studies can also 
define whether the relationships between childhood and adult traits, for example, birth 
weight and cardiovascular disease, are causally mediated by early life exposures. In 
addition, genetics can support how specific environmental factors contribute to variation in 
these traits, i.e., whether there is gene-environment interaction with the increase in risk 
depending on an individual’s genetic risk.     
It is increasingly recognized that large sample sizes are essential in genetic research [14] 
and studies performed in large international consortia have become the norm. Two such 
consortia with a particular focus on the genetics of early life phenotypes are the Early 
Growth Genetics (EGG) consortium (http://egg-consortium.org/) and the EArly Genetics and 
Lifecourse Epidemiology (EAGLE) consortium (http://www.wikigenes.org/e/art/e/348.html ) 
(Figure 1). This paper describes these two consortia as they have shared objectives and the 
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participating cohorts partly overlap. We also highlight the results so far and outline the 
directions of future research.  
 
Description and aims of the EGG and EAGLE consortia 
Both consortia arose in 2009 out of the EU-funded European Network for Genetic And 
Genomic Epidemiology (ENGAGE). The EGG consortium focuses on the genetic basis of 
growth-related phenotypes spanning from fetal life into adolescence, including birth 
weight, childhood obesity and pubertal development. EAGLE was established to investigate 
the genetic basis of the wide range of further phenotypes collected by these cohorts from 
fetal life into adolescence, such as those relevant to asthma and eczema, childhood 
psychopathology, cognition, and neurodevelopment. The collective objectives of EGG and 
EAGLE are: 
1. to characterize the genetic background of traits and diseases in fetal life, childhood and 
adolescence by facilitating collaboration between pregnancy, birth, childhood and 
adolescent cohort studies, as well as adult biobanks (such as UK Biobank) with relevant 
information; 
2. to define the causal relationships between early life exposures and related early life 
phenotypes and major sources of morbidity and mortality in later life; 
3. to develop and improve statistical methods for analyzing complex, high-dimensional 
and longitudinal phenotypic data; 
4. to provide training opportunities for junior researchers to develop in the field of genetic 
epidemiology.  
The EGG and EAGLE consortia started as collaborations of population-based pregnancy and 
birth cohort studies, each of which has collected longitudinal data across a wide range of 
developmental phenotypes. As the collaboration developed, cohorts that started data 
collection during childhood and adolescence were also included. Almost all participating 
studies have genome-wide genotype data available. In addition, early life data collected 
through self-report and/or record linkage in adult biobanks, such as UK Biobank or the 
population based cohorts listed in Table 1 that have an adult counterpart, have been 
brought into the genome-wide association (GWA) meta-analyses for phenotypes such as 
birth weight. Both consortia welcome new collaborations, and they are keen to add data 
from longitudinal cohorts that are currently in the process of obtaining genotype data. 
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Table 1 and 2 provides a summary of the participating studies and their design, as of April 
2018. Table 3 gives further details on the extensive data available, indicating, per cohort, 
whether data collection has taken place at least once at preschool, school, adolescent and 
adult age. However, many cohorts have had multiple follow-up rounds within any given 
period or follow-up data collection is ongoing, through research clinic assessments, 
questionnaires or record linkage. The majority of the cohorts have around equal numbers of 
males and females included.  
Most cohorts were established with the aim of investigating risk and protective factors for a 
broad range of developmental phenotypes. They have collected data on physical traits, 
cognition, emotional and behavioral problems, as well as on lifestyle and environmental 
factors, such as smoking during pregnancy and physical exercise. Other cohorts were set up 
with a specific focus, such as asthma research, but many of these have collected ancillary 
information on a wider range of phenotypes. Table 2 gives an indication as to whether data 
collection was focused on a specific phenotype. Additional details on many of these studies 
will be available from cohort websites and publications (see Table 1). 
Participating cohorts have obtained DNA from blood samples, saliva or buccal swabs. A 
variety of different genotyping arrays have been used over the years, but meta-analysis has 
been facilitated by imputation of directly genotyped data using reference panels such as 
those generated by 1000 Genomes or the Haplotype Reference Consortium [15, 16].  
Moreover, an increasing number of cohorts have, or plan to get, additional ‘omics data 
including parental genotypes, DNA methylation profiles, RNA expression levels, 
metabolomics and/or microbiome data. 
 
Results of the genetic studies performed in the EGG and EAGLE consortia 
The implementation of GWA meta-analyses for each of the phenotypes of interest to EGG 
or EAGLE has usually been championed and organized at the level of a working group, 
formed by a subset of motivated investigators and analysts, who have assumed 
responsibility for assembling, combining and interpreting the genetic data. The wide range 
of phenotypes available to study across these consortia has provided fertile ground for 
many such working groups and has resulted in a large number of peer-reviewed papers 
across this wide range of phenotypes [17-45]. These are typically GWA meta-analyses, 
focusing on the effects of individual genetic variants, but increasingly now extend to 
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multivariate, polygenic analyses, that evaluate the joint effects of multiple associated 
genetic variants and apply this information to address questions of causality.  
Amongst the many GWA analyses led by EGG and EAGLE, the traits for which the largest 
numbers of genetic loci reached genome-wide statistical significance (p < 10-8) have been 
birth weight (65 loci), atopic dermatitis (31), childhood BMI (15), allergic sensitization (10), 
and pubertal growth (10) [17, 19, 23, 26, 28, 36]. For other phenotypes with a large number 
of genome wide hits, such as age at menarche (108 loci) or ADHD (16 loci), the association 
analysis has involved collaborations with other consortia [25, 37]. The summary statistics 
for many of the genome-wide association studies undertaken by EGG and EAGLE 
investigators can be found on consortium websites (http://egg-consortium.org/; 
http://www.wikigenes.org/e/art/e/348.html) or are available from corresponding authors. 
As with adult phenotype GWA studies, the number of association signals recovered by 
these studies is influenced heavily by sample size (N=182,416 for age at menarche, 
N=153,781 for birth weight) and, to a lesser extent, by phenotype characteristics (somatic 
or behavioral traits, continuous or binary outcomes).  
In addition to cross-sectional GWA analyses, there have been many examples of projects 
that have investigated genetic relationships within childhood traits or between childhood 
traits and related adult phenotypes, often revealing shared genetic factors. For example, 
genetic overlap was found among related atopic conditions during childhood, and between 
atopic conditions and auto-immune disorders [19, 36]; among puberty-related phenotypes, 
and between puberty-related phenotypes and BMI [23, 24, 37]; between childhood and 
adult blood pressure [41];  between preschool internalizing symptoms and adult psychiatric 
disorders [18]; and between childhood and adult anthropometric traits [21, 26, 40, 44]. The 
development of statistical methods that support the calculation of genetic correlations 
from summary GWAS results [46] and the easy availability of such data from a growing 
number of GWA meta-analyses for adult traits have enabled these analyses to be 
undertaken with adequate statistical power.  
Figure 2 shows genetic correlations, calculated exclusively from GWAS data, between birth 
weight and a range of continuous and disease phenotypes [28], generated using the linkage 
disequilibrium score regression approach [46] as implemented in the LDHub web utility 
[47]. For many cardiometabolic and anthropometric traits measured in late adult life, there 
is evidence of substantial sharing of genetic variation with birth weight. In line with the 
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wider epidemiological data, the genetic correlations between birth weight and adult 
cardiometabolic traits (including type 2 diabetes, blood pressure, and coronary artery 
disease) tend to be negative. These data indicate that a substantial proportion of the 
observed covariance between birth weight and cardiometabolic disease predisposition is 
likely to be driven by genetic rather than environmental factors. However, the potential for 
more complex causal relationships (such as those that connect fetal genotype to adult 
disease via the correlation with maternal genotype and altered maternal environment) also 
needs to be considered. Full characterization of these complex relationships requires the 
application of statistical methods that enable partitioning of genetic effects into maternal 
and fetal components both at the level of individual SNPs [48] and genome-wide [49]. Using 
the M-GCTA method [49], for example, it has been reported that maternal genotypes 
contribute more to gestational weight gain in the mother, while offspring genotypes 
contribute more to birth weight [45].  
Another critical advantage of genetic studies is the potential to characterize causal 
relationships using Mendelian randomization approaches [50]. Tyrrell et al [42] found 
evidence of a positive causal effect of maternal BMI and fasting glucose levels on offspring 
birth weight but inverse effect of maternal systolic blood pressure on offspring birth weight. 
Despite bringing together the largest number of studies at the time with relevant data, 
there was insufficient power to dissect how the opposing effects of maternal glucose and 
systolic blood pressure are reflected in the maternal BMI effect (one reason why we are 
keen to extend the collaboration to any new cohorts). Crucially, however, appropriate 
application and interpretation of studies that seek to elucidate the mechanisms underlying 
associations between maternal and offspring phenotypes require investigators to consider 
diverse complicating factors including the correlation between maternal and fetal genetic 
instruments, and to account for these sources of potential bias in the Mendelian 
randomization analyses wherever possible [51]. 
The longitudinal data collected in EGG and EAGLE cohorts provide the means to investigate 
whether the influence of genetic variants changes over time. This has only recently been 
explored given the need for large numbers of studies with repeated measures. We have 
found that genetic variation in FTO , one of the first BMI increasing genetic variants to be 
identified in GWAS and one of the variants most strongly associated with mean BMI (in 
adults) is inversely associated with BMI in infancy only becoming positive in later childhood 
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and adult [38], indicating the value of research that explores gene-by-age interactions. On a 
genome-wide scale, using meta-regression methods, polygenic risk scores generated from 
adult schizophrenia data yielded associations with variation in childhood and adolescent 
psychiatric symptom scores, which strengthened in magnitude with increasing age [55].      
 
Strengths and weaknesses 
The aggregation of data in consortia such as EGG and EAGLE provides vastly improved 
sample sizes and a powerful way to overcome the major weakness of many of the early 
GWAS, which were, in hindsight, underpowered to detect the generally small genome-wide 
significant associations. This has brought multiple robust association signals across many 
traits, and provided a valuable basis for dissecting the, often complex, causal relationships 
between epidemiologically-correlated traits.  
A clear strength of the EGG and EAGLE consortia is the wealth of data available. This 
encompasses not only repeated measures for physical and behavioral traits, but also 
copious information on lifestyle and environmental circumstances. Moreover, some of the 
cohorts have collected data for several decades, and now provide repeated measures well 
into adulthood. This enables developmental research as well as analyses of the interplay 
between genes and environment.  
To date, one of the limitations has been that the majority of participating cohorts have data 
based on European-ancestry populations (see Table 2 for exceptions). There is a clear need 
for equivalent data to be generated in samples from other ethnic groups, so that the 
genetic contribution to reproducible ethnic differences in the distribution of early life 
phenotypes can be explored and the implications for adult disease risk quantified.  
Since the cohorts are population-based and lack a particular disease-focus, the consortia 
are not so well-suited to investigate conditions with a low prevalence. They are better-
placed to analyze common traits, particularly those that can be measured on continuous 
scales and analyzed as quantitative measures, such as blood pressure instead of 
hypertension and ADHD symptom score instead of ADHD diagnosis [32, 34]. Power analyses 
demonstrate that identification of a genetic variant is, in most circumstances, more 
powerful for continuous traits than for dichotomous variables based on clinical cut-offs 
[56].  
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Future 
Considerable progress is to be expected from ongoing increases in sample sizes, especially 
for traits such as childhood aggression, ADHD-related traits and internalizing symptoms, 
where the number of identified genetic variants has been limited so far. Access to new data 
sets can motivate efforts to tackle phenotypes that have not hitherto been subject to 
detailed genetic analysis.   
The results emerging from many of these studies provide a timely reminder that analysis of 
early life phenotypes often requires researchers to consider the joint impacts of multiple 
genomes (e.g., those of the fetus and the mother) together with the web of environmental 
influences as potential contributors to individual variation. They also highlight the need to 
take into account the changes happening throughout development. This is now possible 
because of large, rich and complex datasets that support use of novel statistical methods 
for the analysis of causality or gene-by-age interaction [48, 49, 51, 57]. There have already 
been several examples of papers performing such analyses and this will only increase with 
the number of identified genetic variants. In addition, existing gender differences in the 
associations between early life and adult factors (such as cardiometabolic risk) suggest a 
need for more thorough analysis of the effects of gender on these early acting mechanisms. 
The focus to date on the role of maternal and offspring GWAS information indicates a 
failure to properly consider the contribution of genetic variation in the father that will be 
remedied as more data from complete trios and pedigrees becomes available.    
We are also planning to expand these consortia to accommodate access to the increasing 
amount of ‘omics data now becoming more available. Combining the results from EGG and 
EAGLE GWA analyses with those from DNA methylation analyses performed by the 
Pregnancy And Childhood Epigenetics (PACE) consortium [58]  and with the pregnancy / 
child cohorts in the COnsortium of METabolomic Studies (COMETS; 
https://epi.grants.cancer.gov/comtets/) will shed further light on the biological mechanisms 
underlying associations of early-life risk factors and childhood, adolescent and adult health 
outcomes. 
The focus on translating this knowledge to clinical and public health settings represents a 
major motivation. Insight into genetic factors underlying stability in traits such as obesity 
and psychiatric disorders may aid in providing targeted interventions to the groups at 
highest need. A more complete understanding of the contributions of genetic and non-
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genetic factors in the relationships between early life and later life traits may focus 
attention on the most effective strategies for behavioural or environmental modification.  
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Table 1: participating cohorts 
Short name Full name cohort website reference 
ABCD Amsterdam Born Children and their 
Development   
https://abcd-studie.nl/ 20813863 
ALSPAC Avon Longitudinal Study on Parents and 
Children     
www.bristol.ac.uk/alspac/ 22507743, 22507742  
 
B58C 1958 British Birth Cohort     www.cls.ioe.ac.uk/page.aspx?&sitesectionid=
724&sitesectiontitle=Welcome+to+the+1958+
National+Child+Development+Study 
16155052, 17255346 
BAMSE Children, Allergy, Milieu, Stockholm, 
Epidemiology   
https://ki.se/en/imm/bamse-project 26505741  
BMDCS Bone Mineral Density in Childhood Study https://bmdcs.nichd.nih.gov/ 17311856 
Breathe BRain dEvelopment and Air polluTion 
ultrafine particles in scHool childrEn   
https://www.isglobal.org/en/-/breathe-brain-
development-and-air-pollution-ultrafine-
particles-in-school-children 
25734425, 27656889 
  
CATSS Child and Adolescent Twin Study in 
Sweden     
https://ki.se/en/meb/the-child-and-
adolescent-twin-study-in-sweden-catss 
22506305 
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CHOP Children’s Hospital of Philadelphia   https://www.caglab.org/ 22138692 
CHS Children’s Health Study https://healthstudy.usc.edu/ 10051249, 10051248, 17307103，
25738666, 28103443, 27115265 
CLHNS Cebu Longitudinal Health and Nutrition 
Survey 
http://www.cpc.unc.edu/projects/cebu 20507864 
 
COPSAC Copenhagen Prospective Studies on 
Asthma in Childhood     
www.copsac.com 15521375, 24118234, 24241537 
DNBC Danish National Birth Cohort      https://www.ssi.dk/English/RandD/Research
%20areas/Epidemiology/DNBC.aspx 
 
EFSOCH  Exeter Family Study of Childhood Health  16466435 
Finntwin12 Finnish Twin Cohort Study https://wiki.helsinki.fi/display/twineng/Twins
tudy 
23298696,17254406, 12537860 
 
Gen3G Genetics of Glucose regulation in 
Gestation and Growth 
n/a 26842272 
 
 Generation R Study https://www.generationr.nl/ 28070760; 25527369 
GINIplus German Infant Study on the influence of 
Nutrition Intervention PLUS environmental 
https://www.helmholtz-
muenchen.de/epi/research/research-
20082618 
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and genetic influences on allergy 
development 
groups/allergy-
epidemiology/projects/giniplus/index.html 
GLAKU Glycyrrhizin in Licorice https://blogs.helsinki.fi/depsy-
group/research/ 
19808634; 17076756; 11390327 
HBCS Helsinki Birth Cohort Study https://thl.fi/en/web/thlfi-en/research-and-
expertwork/projects-and-
programmes/helsinki-birth-cohort-study-
hbcs-idefix 
11312225 
  
Health2006  Helbred2006  https://clinicaltrials.gov/ct2/show/NCT003166
67 
23615486 
INMA INfancia y Medio Ambiente  http://proyectoinma.org/en_index.html 21471022 
Inter99  The Inter99 Study  https://www.regionh.dk/rcph/population-
based-epidemiology/Pages/The-Inter99-
Study.aspx 
14663300 
LISA Influence of life-style factors on the 
development of the immune system and 
allergies in East and West Germany 
https://www.helmholtz-
muenchen.de/epi/research/research-
groups/allergy-
epidemiology/projects/lisa/index.html 
12358337 
 
MAAS Manchester Asthma and Allergy Study   http://maas.org.uk/ 25805205, 15029579, 12688622 
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MOBA Norwegian Mother and Child Cohort Study     https://fhi.no/studier/moba/ 27063603,  
MUSP Mater University Study of Pregnancy https://social-science.uq.edu.au/mater-
university-queensland-study-pregnancy 
25519422 
NTR Netherlands Twin Register   http://www.tweelingenregister.org/ 23186620; 23265630 
NFBC1966 and 
NFBC1986 
Northern Finland Birth Cohort   http://www.oulu.fi/nfbc/ 750195; 19060910; 9246691 
PIAMA Preventie en Incidentie van Astma en Mijt 
Allergie   
http://piama.iras.uu.nl/ 12688626, 23315435 
 Project Viva http://dacp.org/viva/ 24639442 
Qtwin Queensland Twin Registry   http://www.qimrberghofer.edu.au/qtwin/ DOI: 
10.1080/00049530410001734865 
Raine The Western Australian Pregnancy Cohort 
(Raine) Study     
https://www.rainestudy.org.au/ 8105165; 23230915; 23301674l; 
26169918; 28064197; 28662683 
SKOT Småbørns Kost Og Trivsel https://skot.ku.dk/om-projektet/english/ 28947836 
STRIP Special Turku Coronary Risk Factor 
Intervention Project 
http://stripstudy.utu.fi/english.html 18430753 
TCHAD Twin Study of Child and Adolescent 
Development   
https://ki.se/en/meb/twin-study-of-child-and-
adolescent-development-tchad 
17539366 
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TDCOB The Danish Childhood Obesity Biobank https://clinicaltrials.gov/ct2/show/NCT00928
473 
 
TEDS Twins Early Development Study     http://teds.ac.uk/  23110994 
TRAILS TRacking Adolescents’ Individual Lives 
Survey   
https://www.trails.nl/ 25431468 
Young Finns The Cardiovascular Risk in Young Finns 
Study 
http://youngfinnsstudy.utu.fi/ 18263651 
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Table 2: Study designs  
Cohort Study design Years of recruitment Country 
ABCD population based pregnancy cohort 2003-2004 The Netherlands 
ALSPAC Population based birth cohort 1990-1992  UK 
B58C Population based birth cohort 1958 UK 
BAMSE Population based cohort 1994-96 Sweden 
BMDCS Multi-center observational cohort 2002-2009 United States 
Breathe Population based cohort 2002-2006 Spain 
CATSS Populaton based twin birth cohort 1992-ongoing Sweden 
CHOP Population based cohort 1988-Present USA 
CHS Community based children cohort 1993-2002 United States 
CLHNS Population based birth cohort 1983-1984 Philippines 
COPSAC-2000 
COPSAC-2010 
COPSAC-REGISTRY 
Asthma Risk Birth Cohort 
Population based Birth Cohort 
Severe Asthma Cases (children)  
From 2000- 
Ongoing From 2010 
Ongoing 
Denmark 
DNBC-GOYA 
DNBC-PTB 
population based pregnancy cohorts From 1997 
Ongoing 
Denmark 
EFSOCH  Community-based pregnancy cohort of parent-offspring 
trios 
2000-2004 United Kingdom 
Finntwin12 Population-based twin-family  cohort 1983-1987 Finland 
Gen3G population based birth cohort 2010-2013 Canada 
Generation R* Population-based birth cohort 2002-2006 The Netherlands 
GINIplus population based birth cohort 1995-98 Germany 
GLAKU Population-based birth cohort 1998 Finland 
HBCS Population-based birth cohort 1934-44  Finland 
Health2006  General population study  2006-2008 Denmark  
INMA Population-based birth cohort 1997 - 2008 Spain 
Inter99  Population-based randomized intervention study  1999-2006 Denmark  
LISA population based birth cohort 1997-99 Germany 
MAAS* Population-based birth cohort 1996/7 UK 
MOBA Population based birth cohort 1999-2008 Norway 
MUSP Pregnancy general population 1981-1984 Australia 
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NTR* Birth general twin population From 86 - ongoing Netherlands 
NFBC1966 and 
NFBC1986 
longitudinal birth cohort 1966 and 1986 Finland 
PIAMA Population based birth cohort, enriched for high risk 
allergy children (allergic mother) 
1996-1997 Netherlands 
Project Viva* population based birth cohort 1999-2002 USA 
Qtwin Longitudinal twin study 1980-2004 Australia 
Raine Longitudinal pregnancy cohort study 1989 - 1991 Australia 
SKOT Observational cohort study, monitoring healthy young 
children from 9-36 months of age.  
2006-2007 (SKOT I); 
2011-2013 (SKOT II)  
Denmark  
STRIP Prospective randomized life-style intervention trial 1990-1992 Finland 
TCHAD Birth general twin population 1985-1987 Sweden 
TDCOB Case-control study  Children and 
adolescence with 
obesity: 2007-2013; 
Population-based 
sample: 2010-2013 
Denmark  
TEDS population based twin birth cohort From 1994 - Ongoing UK 
TRAILS-pop 
TRAILS-CC 
Population Based  
High Risk  
2001/02,  
2004  
Netherlands 
Netherlands 
Young Finns Population based follow-up from childhood to 
adulthood 
1980 Finland 
*Includes individuals from non-European descent 
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Table 3: Data collected 
Cohort N 
genotyped 
children* 
Phenotypes Age periods data available 
Pregnancy Pre-school School Adolescence adult 
ABCD 1192 Broad x x x x  
ALSPAC 10000 Broad x x x x x 
B58C 6491  Broad x x x x x 
BAMSE 2500 Broad x x x x x 
BMDCS 1885 Broad  x x x x 
Breathe 1667 Broad   x   
CATSS 13,576 Broad, focus on psychiatry x, information 
from registers 
 x x x 
CHOP 43320 Broad  x x x  
CHS 3986 Broad, focus on respiratory and metabolic 
health 
  x x  
CLHNS 1779 Broad  x x x x 
COPSAC-2000 
COPSAC-2010 
COPSAC-
REGISTRY 
411 
700 
1240 
Broad 
Broad 
Broad 
x 
x 
x 
x 
x 
x 
x 
x 
x 
 
 
 
x 
DNBC 
-GOYA 
DNBC 
-PTB 
1500  
 
1500  
Broad x x x x  
EFSOCH  812  Anthropometric and glycemic traits  x x   parents only 
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Finntwin12 1264 Broad retrospective  retrospective  x x x 
Gen3G 582 Broad, focus on metabolic/adiposity x on-going    
Generation R 5731 Broad x x x x   
GINIplus 835 
 
broad x x x x ongoing 
GLAKU 357 Broad x x x x x 
HBCS 1566 Broad  x x x x 
Health2006  2,802 Cardiovascular disease, type 2 diabetes, and 
other lifestyle related diseases 
    x 
INMA 1517 Broad x x x ongoing  
Inter99  6184 Cardiovascular disease, type 2 diabetes, other 
lifestyle related diseases, glucose tolerance 
    x 
LISA 674 
 
broad x x x x ongoing 
MAAS 919 asthma and allergy focused x x x x ongoing 
MOBA 17000  broad x x x x x 
MUSP 1200 Broad x x x x x 
NTR 7750 Broad x x x x ongoing 
NFBC1966 
NFBC1986 
5402 
3743 
Broad x x x x x 
PIAMA 2113 Broad, focus on respiratory health x x x x  
Project Viva 1580 Broad x x x x  
Qtwin 4500 Broad   x x x 
  
24 
 
Raine 1500 Broad x x x x ongoinh 
SKOT I  
SKOT II 
260  
112  
Dietary intake, growth, cognitive 
development, overweight and lifestyle 
related diseases  
 x    
STRIP 666 Broad x x x x x 
TCHAD 990 Broad   x x x 
TDCOB 1,771  Overweight and Obesity   x x x x 
TEDS 10346  Broad  x x x x 
TRAILS-pop 
TRAILS-CC 
1354 
341 
Broad retrospective 
 
retrospective retrospective x x 
Young Finns 2442 Broad x x x x x 
*Some cohorts also have genotype data on parents. 
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 Figure 1. Logo’s  
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Figure 2 Genome-wide genetic correlation between birth weight and a range of traits and 
diseases in later life. Genome-wide genetic correlations between birth weight and traits 
and diseases evaluated in later life. The figure (adapted from Horikoshi et al 2016 [28] with 
permission of the authors) displays the genetic correlations between birth weight and a 
range of traits and diseases in later life as estimated using LD Score regression. Traits 
selected were those for which genome-wide association summary statistics were available in 
suitably large sample sizes, and the analyses were typically performed on the largest meta-
analyses available as of early 2016.  The genetic correlation estimates (rg) are colour coded 
according to phenotypic area. Allelic direction of effect is aligned to increased birth weight. 
Size of the circle denotes the significance level for the correlation (per the key). Correlations 
with a lower significance level are not depicted. Further detail on the methods and studies 
involved is available in Horikoshi et al 2016 [28].  
 
Diameter of circles is proportional to genetic correlation p-value.  
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